Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease

M. Leifheit-Nestler, R. Große Siemer, K. Flasbart, B. Richter, F. Kirchhoff, WH. Ziegler, M. Klintschar, JU. Becker, A. Erbersdobler, C. Aufricht, T. Seeman, DC. Fischer, C. Faul, D. Haffner,

. 2016 ; 31 (7) : 1088-99. [pub] 20151217

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031880

BACKGROUND: In chronic kidney disease (CKD), serum concentrations of fibroblast growth factor 23 (FGF23) increase progressively as glomerular filtration rate declines, while renal expression of the FGF23 coreceptor Klotho decreases. Elevated circulating FGF23 levels are strongly associated with mortality and with left ventricular hypertrophy (LVH), which is a major cause of cardiovascular death in CKD patients. The cardiac FGF23/FGF receptor (FGFR) system and its role in the development of LVH in humans have not been addressed previously. METHODS: We conducted a retrospective case-control study in 24 deceased patients with childhood-onset end-stage renal disease (dialysis: n = 17; transplanted: n = 7), and 24 age- and sex-matched control subjects. Myocardial autopsy samples of the left ventricle were evaluated for expression of endogenous FGF23, FGFR isoforms, Klotho, calcineurin and nuclear factor of activated T-cells (NFAT) by immunohistochemistry, immunofluorescence microscopy, qRT-PCR and western blotting. RESULTS: The majority of patients presented with LVH (67%). Human cardiomyocytes express full-length FGF23, and cardiac FGF23 is excessively high in patients with CKD. Enhanced myocardial expression of FGF23 in concert with Klotho deficiency strongly correlates with the presence of LVH. Cardiac FGF23 levels associate with time-averaged serum phosphate levels, up-regulation of FGFR4 and activation of the calcineurin-NFAT signaling pathway, an established mediator of cardiac remodelling and LVH. These changes are detected in patients on dialysis but not in those with a functioning kidney transplant. CONCLUSIONS: Our results indicate a strong association between LVH and enhanced expression levels of FGF23, FGFR4 and calcineurin, activation of NFAT and reduced levels of soluble Klotho in the myocardium of patients with CKD. These alterations are not observed in kidney transplant patients.

000      
00000naa a2200000 a 4500
001      
bmc17031880
003      
CZ-PrNML
005      
20171025115628.0
007      
ta
008      
171025s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ndt/gfv421 $2 doi
035    __
$a (PubMed)26681731
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Leifheit-Nestler, Maren $u Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
245    10
$a Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease / $c M. Leifheit-Nestler, R. Große Siemer, K. Flasbart, B. Richter, F. Kirchhoff, WH. Ziegler, M. Klintschar, JU. Becker, A. Erbersdobler, C. Aufricht, T. Seeman, DC. Fischer, C. Faul, D. Haffner,
520    9_
$a BACKGROUND: In chronic kidney disease (CKD), serum concentrations of fibroblast growth factor 23 (FGF23) increase progressively as glomerular filtration rate declines, while renal expression of the FGF23 coreceptor Klotho decreases. Elevated circulating FGF23 levels are strongly associated with mortality and with left ventricular hypertrophy (LVH), which is a major cause of cardiovascular death in CKD patients. The cardiac FGF23/FGF receptor (FGFR) system and its role in the development of LVH in humans have not been addressed previously. METHODS: We conducted a retrospective case-control study in 24 deceased patients with childhood-onset end-stage renal disease (dialysis: n = 17; transplanted: n = 7), and 24 age- and sex-matched control subjects. Myocardial autopsy samples of the left ventricle were evaluated for expression of endogenous FGF23, FGFR isoforms, Klotho, calcineurin and nuclear factor of activated T-cells (NFAT) by immunohistochemistry, immunofluorescence microscopy, qRT-PCR and western blotting. RESULTS: The majority of patients presented with LVH (67%). Human cardiomyocytes express full-length FGF23, and cardiac FGF23 is excessively high in patients with CKD. Enhanced myocardial expression of FGF23 in concert with Klotho deficiency strongly correlates with the presence of LVH. Cardiac FGF23 levels associate with time-averaged serum phosphate levels, up-regulation of FGFR4 and activation of the calcineurin-NFAT signaling pathway, an established mediator of cardiac remodelling and LVH. These changes are detected in patients on dialysis but not in those with a functioning kidney transplant. CONCLUSIONS: Our results indicate a strong association between LVH and enhanced expression levels of FGF23, FGFR4 and calcineurin, activation of NFAT and reduced levels of soluble Klotho in the myocardium of patients with CKD. These alterations are not observed in kidney transplant patients.
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibroblastové růstové faktory $x metabolismus $7 D005346
650    _2
$a lidé $7 D006801
650    _2
$a hypertrofie levé komory srdeční $x etiologie $x metabolismus $x patologie $7 D017379
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a receptor fibroblastových růstových faktorů, typ 4 $x metabolismus $7 D051499
650    _2
$a chronická renální insuficience $x komplikace $7 D051436
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Große Siemer, Robert $u Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
700    1_
$a Flasbart, Kathrin $u Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
700    1_
$a Richter, Beatrice $u Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
700    1_
$a Kirchhoff, Felix $u Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
700    1_
$a Ziegler, Wolfgang H $u Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
700    1_
$a Klintschar, Michael $u Institute for Forensic Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
700    1_
$a Becker, Jan U $u Institute of Pathology, University Hospital Cologne, Kerpener Str. 62, 50937 Cologne, Germany.
700    1_
$a Erbersdobler, Andreas $u Institute of Pathology, University Hospital Rostock, Strempelstr. 14, 18055 Rostock, Germany.
700    1_
$a Aufricht, Christoph $u Division of Pediatric Nephrology, University Children's Hospital Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria. $7 gn_A_00010004
700    1_
$a Seeman, Tomas $u Division of Pediatric Nephrology, University Children's Hospital Motol, V Uvalu 84, 15006, Prague, Czech Republic.
700    1_
$a Fischer, Dagmar-Christiane $u Department of Pediatrics, University Hospital Rostock, Ernst-Heydemann-Str. 8, 18057 Rostock, Germany.
700    1_
$a Faul, Christian $u Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, 1580 NW 10th Avenue (R-762), Miami, FL 33136, USA.
700    1_
$a Haffner, Dieter $u Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
773    0_
$w MED00010288 $t Nephrology, dialysis, transplantation official publication of the European Dialysis and Transplant Association - European Renal Association $x 1460-2385 $g Roč. 31, č. 7 (2016), s. 1088-99
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26681731 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025115710 $b ABA008
999    __
$a ok $b bmc $g 1255473 $s 992907
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 31 $c 7 $d 1088-99 $e 20151217 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace